IN SILICO DOCKING OF QUERCETIN COMPOUND AGAINST THE HELA CELL LINE PROTEINS

Authors

  • Borappa Muthukala PG and Research Department of Zoology, Presidency College, Chennai-5, Tamil Nadu, India
  • Kanakarajan Sivakumari PG and Research Department of Zoology, Presidency College, Chennai-5,Tamil Nadu, India
  • Kamalanathan Ashok PG and Research Department of Zoology, Presidency College, Chennai-5, Tamil Nadu, India

Keywords:

In silico docking, Quercetin, Auto Dock

Abstract

The present molecular docking study can be useful for the design and development of novel compound having better inhibitory activity against human cervical cancer cell line proteins. The docking scores were highest for cellular tumor antigen p53 with -4.52 kcal/mol with the stronger interaction followed by Caspase-3 (-4.09 kcal/mol.), Mucosal address in cell adhesion molecule 1(-4.0 kcal/mol) and the last score was found in the NF-kappaB (-2.83 kcal/mol) and the LogP, lower hydrogen bond counts, confirming the capability of the Quercetin for binding at the active site of the receptor. These potential drug candidates can further be validated in wet lab studies for its proper function.

Downloads

Download data is not yet available.

References

WHO. Death and DALY Estimates for 2004 by Cause for WHO Member States; 2004;1:1-5.

Kurkure AP, Yeole BB. Social inequalities in cancer with special reference to South Asian countries. Asian Pacific J Cancer Prev 2006;7(1);36-40.

Waggoner SE. Antioxidant and antimicrobial activity of herbal plants. Lancet 2003;361(9376):2217-25.

Caroline Horvath AJ, Gaelle Boulet AV, Virginie Renoux M, Philippe Delvenne O, John-Paul JB. Mechanisms of cell entry by human papillomaviruses: an overview. Virol J 2010;7:11.

Sureshkumar P, Senthilraja O, Kalavathy S. In silico docking analysis of Calotropis gigantean (l.) R. BR derived compound against anti-cervical activity. Bioinfo Publication 2012;1(1);9-12.

Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993b;20;21-9.

Rice Evans C, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.

De Whalley C, Rankin SM, Hoult JR, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990;39:1743-50.

Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998;275:212-9.

Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993a;342:1007-11.

Hollman PC, de Vries JH, Van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62:1276-82.

Hollman PC, van der Gaag M, Mengelers MJ, van Trijp J, de Vries J, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996a;21:703-7.

Hollman P, Buysman MP, van Gameren Y, Cnossen E, de Vries J, Katan M. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Rad Res 1999;31:569-73.

Engelhardt U, Finger A, Herzig B, Kuhr S. Determination of flavonol glycosides in black tea. Dtsch Lebensm-Rundsch 1992;88:69-73.

Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993b;20:21-9.

Kiviranta J, Huovinen K, Hiltunen R. Variation in phenolic substances in onion. Acta Pharm Fenn 1988;97:67-72.

Bokkenheuser VD, Shackleton CH, Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. J Biochem 1987;248:953-6.

Gunata Z, Bitteur S, Brillout JM, Bayonove C, Cordonnier R. Sequential enzymatic hydrolysis of potentially aromatic glycosides from grapes. Carbohydrate Res 1988;184:139-49.

Kurosawa Y, Ikeda K, Egami F. Alpha-L-rhamnosidases of the liver of Turbo cornutus and Aspergillus niger. J Biochem 1973;73:31-7.

Olthof MR, Hollman PC, Vree TB, Katan MB. Bioavabilities of Quercetin-4’-Glucoside do not differ in humans. J Nutr 2000;1:1200-3.

Materska M. Quercetin and its derivaties: chemical structure and bioactivity-A review. Pol J Food Nutri Sci Bol 2008;58(4):407-4013.

Mittal RR, McKinnon RA, Sorich MJ. Comparison data sets for benchmarking QSAR methodologies in lead optimization. J Chem Inf Model 2009;49:1810â€20.

Published

06-01-2015

How to Cite

Muthukala, B., K. Sivakumari, and K. Ashok. “IN SILICO DOCKING OF QUERCETIN COMPOUND AGAINST THE HELA CELL LINE PROTEINS”. International Journal of Current Pharmaceutical Research, vol. 7, no. 1, Jan. 2015, pp. 13-16, https://journals.innovareacademics.in/index.php/ijcpr/article/view/4708.

Issue

Section

Original Article(s)